Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Home > ½ÃÀ庸°í¼­ > ÆÄ¸Ó½´Æ¼Äà > ¹é½Å > U.S. Non-Infectious Disease Vaccine Pipeline
Ä«Å×°í¸®
ÆÄ¸Ó½´Æ¼Äà (4931)
°¨¿°Áúȯ (349)
°ñÁúȯ Ä¡·á (38)
´ç´¢º´ (194)
¹é½Å (181)
ºñ¸¸Ä¡·á/´ÙÀÌ¾îÆ® (44)
ºñó¹æ ÀǾàǰ (152)
¼öÀÇÇÐ (17)
½Å°æÁúȯ (174)
½Å¾à°³¹ß (1529)
¾ÏÄ¡·á (941)
¾à¹°Àü´Þ (185)
ÀǾàǰ ±ÔÁ¦È¯°æ (127)
Á¤½ÅÁúȯ (86)
Á¦³×¸¯ ÀǾàǰ (128)
Á¦¾àȸ»çºÐ¼® (523)
󹿾à (165)
½ÃÀ庸°í¼­

U.S. Non-Infectious Disease Vaccine Pipeline

¸®¼­Ä¡»ç Frost & Sullivan
¹ßÇàÀÏ 2008³â 04¿ù »óǰÄÚµå 64750
ÆäÀÌÁö Á¤º¸ 65 Pages
°¡°Ý
US $ 6,000 £Ü 7,149,000 Web Access (Regional License)
US $ 6,500 £Ü 7,744,700 Hard Copy & Web Access (Regional License)


¿µ¹®¸ñÂ÷

Abstract

The U.S. Non-Infectious Disease Vaccine Pipeline research service contains an overview of the vaccine pipeline and development information for non-infectious diseases (Oncology, Cardiovascular, Multiple Sclerosis, Addiction Disorders). The research service also provides an overview of vaccine development, major challenges, and conclusions.

Table of Contents

1 U.S. NON-INFECTIOUS DISEASES VACCINE PIPELINE

  • Introduction and Scope
    • Title
    • Disclaimer
    • Certification
    • Table of Contents
    • Introduction and Scope
  • Vaccine Development
    • Clinical Development
    • Challenges
    • Market Trends
  • Cancer Vaccine Pipeline by Disease
    • Cancer Vaccine Pipeline by Disease
    • Acute Myelogenous Leukemia
    • Breast Cancer
    • Chronic Myleoid Leukemia
    • Colorectal Cancer
    • Esophageal Cancer
    • Glioblastoma Multiforme
    • Head and Neck Cancer
    • Liver Cancer
    • Lung Cancer
    • Melanoma
    • Non-Hodgkin Lymphoma
    • Ovarian Cancer
    • Pancreatic Cancer
    • Prostate Cancer
    • Renal Cell Carcinoma
  • Addiction Vaccine Pipeline by Disease
    • Addiction Vaccine Pipeline by Disease
    • Cocaine Abuse
    • Nicotine Abuse
  • Cardiovascular Disease Vaccine Pipeline by Disease
    • Cardiovascular Disease Vaccine Pipeline by Disease
    • Hyperlipidemia
    • Hypertension
  • Multiple Sclerosis Vaccine Pipeline
    • Multiple Sclerosis Vaccine Pipeline
    • Multiple Sclerosis
  • Conclusion
    • Conclusion Introduction
    • Conclusion
  • Appendix
    • About Frost & Sullivan
Back to Top